'This is also a broader issue. The UK’s share of global pharma R&D has dropped sharply since 2012, from 7.7 per cent to 4.2 per cent in 2020. Manufacturing has fallen since 2015, according to the Association of the British Pharmaceutical Industry, along with exports. '

https://www.ft.com/content/aed6c929-6eeb-4f6d-bce7-d36445fc5ebf